Clinical Evaluation of Multiple Valve Replacement

심장다판치환술의 임상적 고찰

  • 오상기 (전남대학교 의과대학 흉부외과학교실)
  • Published : 2000.02.01

Abstract

Background: The purpose of this study is to evaluate and analyze the surgical results in patients undergoing operations for multiple for multiple valvular heart diseases. Material and method: From April 1982 to June 1997 multiple valve replacement was performed in 150 patients mitral and aortic valve replacement were done in 135 patients mitral and tricuspid valve replacements in 10 patients triple replacements in 4 patients and aortic and tricuspid valve replacement in 1 patient. Of the valves implanted 157 were St. Jude 104 Duromedics 20 Carpenter-Edwards 6 Bjork-Shiley 6 Ionescu-Shiley and 2 Medtronics. Result: The hospital mortality rate was 10.7% (16/150) and the late mortality rate was 7.2% (8/134) The mortality rate was high in early operative period but decreased with time. The causes of death were low cardiac output in 9 sudden death in 3 congestive heart failure in 3 bleeding in 2 cerebral thrombosis in 1 leukemia in 1 multiorgan failure in 1 and so on . The actuarial survival rate excluding operative death was 83.1% at 15 years. Conclusion: With a follow-up now extending to 15 years the multiple valve replacement continues to be reliable procedure with relatively low mortality and morbidity.

Keywords

References

  1. J Thorac Surg v.35 The surgical treatment of stenotic and regurgitant lesions of the mitral and aortic valves by direct vision utilizing a pump-oxygenator Lillehei CW.;Gott VL.;DeWall RA.;Varco RL.
  2. J Thorac Cardiovasc Surg v.45 Combined aortic and mitral valve replacement Cartwright RS.;Giacobine JW.;Rantan RS.;Ford WB.;Palich WE.
  3. 대흉외지 v.28 다중판막치환술의 임상성적 최순호;이삼윤;김형곤
  4. Ann Thorac Surg v.43 The determinants of mortality and morbidity after multiple-valve operations Teoh KH.;Christakis GT.;Weisel RD.;et al.
  5. J.Am Coll Cardiol v.19 Multiple Valve Operation for Advanced Valvular Heart Disease;Result and Risk Factors in 513 patients Galloway AC.;Crossi EA.;Baumann FG.;et al.
  6. 대흉회지 v.31 중복판막수술후 조기성적에 영향을 미치는 인자에 관한 연구 한일룡;조용길;황윤호;조광현
  7. Ann Thorac Surg v.23 Triple valve replacement;An analysis of eight years experience Stephenson LW.;Kouchoukos NT.;Kirklin JW.
  8. Chrchill Livingstone Inc.(2nd ed.) Combined aortic and mitral valve disease with or without tricuspid valve disease.Cardiac Surgery Carpentier A.
  9. 대흉외지 v.27 St.Jude Medical 판막의 임상성적 김상형;장원채
  10. Ann Thorac Surg v.34 Thromboembolic complication of current cardiac valve prosthesis Edmunds LH Jr.
  11. Ann Thorac Surg v.44 Implantation of the Duromedics gileaflet cardiac valve prosthesis in 400 patients Klepetko W.;Moritz A.;Khunl-Brady G.;et al.
  12. 대흉회지 v.30 St.Jude 기계판막을 이용한 판막치환술의 장기성적 김창곤;구자홍;조중구;김공수
  13. 대흉회지 v.28 센트쥬드 중복판막치환의 장기 임상성적 김종환
  14. J Thorac Cardiovasc Surg v.95 Medtronic Hall valve replacement in a thirdworld population group a revies of the performance of 1000 prosthesis Antunes MJ.;Wessels A.;Sadowski RG.;Schutz JG.;Vanderdonck KM.
  15. Ann Thorac Surg v.45 Long-term results of mitral valve surgery in patients with severe pulonoary hypertension Camara ML.;Aris A.;Padro JM.;Caralps JM.
  16. Archives des Maladies Du Coeuret des Vaisseaux v.85 Acar J.Prognosis of reoperation for prosthesis dysfunction Nallet O.;Roger V.;Michel PL.;Remadi F.;Farah E.